Single-dose and multiple-dose pharmacokinetics of zaltoprofen after oral administration in healthy Chinese volunteers

Journal of Biomedical Research

Volumn 25, Issue 1, 2011, Pages 56-62

  Li, Lingjun ^a   Ma, Pengcheng ^a   Cao, Yuping ^a   Tao, Lei ^a   Tao, Yue ^a  

^a INSTITUTE OF DERMATOLOGY   (China)

Author keywords

Nonsteroidal anti inflammatory drug; Pharmacokinetics; Zaltoprofen

Indexed keywords

KETOPROFEN; ZALTOPROFEN;

ABSENCE OF SIDE EFFECTS; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CHINESE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SINGLE DRUG DOSE;

EID: 79951731051     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1674-8301(11)60007-9     Document Type: Article

References (6)

1. Tsurumi K, Kyuki K, Niwa M, Kokuba S, Fujimura H Pharmacological investigations of the new antiinflam-matory agent 2-(10, 11-dihydro-10-oxodibenzo[b, f]thiepin-2-yl) propionic acid. 1st communication: inhibitory effects of rat paw edema. Arzneimittelforschung 1986, 36:1796-1800.
2. Kameyama T, Nabeshima T, Yamada S, Sato M Analge-sic and antiinflammatory effects of 2-(10, 11-dihydro-10-oxo-dibenzo[b,f]thiepin-2-yl)propionic acid in rat and mouse. Arzneimittelforschung 1987, 37:19-26.
3. Tsurumi K, Kyuki K, Niwa M, Mibu H, Fujimura H Phar-macological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 2nd communication: inhibitory effects on acute inflammation and prostaglandin-related reactions. Arzneimittelforschung 1986, 36:1801-1805.
4. Misaki Matsumoto, Makoto Inoue, Hiroshi Ueda NSAID zaltoprofen possesses novel anti-nociceptive mechanism through blockage of B2-type bradykinin receptor in nerve endings. Neurosci Lett 2006, 397:249-253.
5. Heon-Woo Lee, Ji-Hyung Seo, Yong-Won Kim, Seo-Young Jeong, Kyung-Tae Lee Determination of zalto-profen in human plasma by liquid chromatography with electrospray tandem mass spectrometry: Application to a pharmacokinetic study. Rapid Commun Mass Spectrom 2006, 20:2675-2680.
6. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for Industry, Bioanalytical Method Validation, May 2001.